This Week in PLOS

In PLOS Genetics, Norwegian researchers explore the genetic heterogeneity of colorectal cancer metastases to the liver in relation to patient outcomes. Using array-based copy number profiles, the team characterized 134 samples from liver metastases in 45 individuals with colorectal cancer, uncovering heterogeneity in CNV patterns both within and between patients. It also saw ties between lower-than-usual tumor heterogeneity and enhanced survival times.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.